
Peptide appearance
Lyophilized form helps protect peptide quality. Peptides are supplied as a dry powder, which may look like a compact "puck" or a lighter powder inside the vial.
Because the peptide is dry, it does not require refrigerated shipping during normal transit, including warm seasonal conditions. For longer storage, follow the storage guidance in the product description.
Appearance can vary. The stated peptide content is checked through third-party analysis.
Read more in the product description.
Solution not bundled
Peptides are delivered as lyophilized powder. This dry form helps preserve peptide quality during storage and transport and does not require refrigerated shipping during normal transit.
To prepare a solution, use a solvent such as Bacteriostatic water. It is sold separately, so add it only when you need it for peptide preparation.
Read more in the product description.
Neuroregulatory peptide
DSIP
In stock
DSIP is a peptide made of nine amino acids. Published studies look at brain signals, metabolism, low-oxygen models, and receptor-related measurements.
Order within — · ships today Cutoff 10:00 · local time
Arrives Sep 21 - Sep 23 to Europe
DSIP
55,50 €
Delta sleep-inducing peptide for neuropeptide, circadian, and stress-pathway studies.
Scroll horizontally to reach every product-information tab.
Research overview
DSIP
DSIP means delta sleep-inducing peptide and refers to a defined nine-amino-acid sequence. Its short sequence supports controlled identity and signalling studies.
Studies include brain recordings, pain-model endpoints, metabolism, low-oxygen conditions, and cell growth. Each report applies only to its own laboratory system.
Brain-signal and receptor studies
Studies examine EEG-related observations and opioid- and GABA-related signalling. They also measure behaviour and brain chemistry in controlled models.
The original study explains what was measured and what its limits are.
Metabolic and cellular models
Other work covers low-oxygen, metabolic, muscle, and cell-growth models. Exact sequence, controls, and test conditions are important when comparing these different studies.
Compound information
Specifications
Molecular profile
- Sequence
- Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Molecular mass
- 848.82 g/mol
- CAS number
- 62568-57-4
- Molecular formula
- C35H48N10O15
Material record
- Physical appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
- Product note
- Delta sleep-inducing peptide; supplied strictly for research use only.
Laboratory care
Handling
Peptides in transport
Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.
Storage of lyophilized peptides
Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Up to 3 months
- Refrigerated (2–8 °C): Up to 6 months
- Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)
Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.
Storage of reconstituted peptides
Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
- Frozen (-20 °C or below): Up to 3–4 months
To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Latest test results
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 10mg

99.7%Purity by HPLC
Recorded QC panel
- AssayPeptide Screening 0.1% TFA
- 14.13 mg (± 0.07 mg)
- PurityPeptide Screening 0.1% TFA
- 99.7%
- Identity (FTIR)Peptide Screening 0.1% TFA
- 983 (± 5)
- Identity (RT)Retention time
- 0.992 (± 0.005)
- Bacterial endotoxinUSP 85 / Eur. Ph. 2.6.14
- 0.335 EU/mg
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
National Center for Biotechnology Information
PubChem Compound Summary: Delta sleep-inducing peptide
Authoritative identity record for DSIP.
PubChem · View source ↗Chemical Abstracts Service
CAS Common Chemistry: 62568-57-4
Authoritative CAS Registry Number record for DSIP.
CAS Common Chemistry · View source ↗Schoenenberger GA, Monnier M · 1977
Characterization of a delta-electroencephalogram (delta-sleep)-inducing peptide
Primary characterisation report for DSIP.
Proceedings of the National Academy of Sciences of the United States of America · 10.1073/pnas.74.3.1282 View source ↗Sukhanova TV, Artyukhov AA, Gurevich YM · 2014
Delta-sleep inducing peptide entrapment in the charged macroporous matrices
Primary materials study using DSIP.
Materials Science and Engineering C · 10.1016/j.msec.2014.05.059 View source ↗National Center for Biotechnology Information
PubChem compound record
PubChem · View source ↗Schaison G, Jacquillat Cl, Weil M, Auclerc MJ, Curely JP, Bernard J · 1977
[Recurrence with gonadic localization of acute leukemia. 113 cases]
La Nouvelle presse medicale · View source ↗Schneider-Helmert D, Gnirss F, Monnier M, Schenker J, Schoenenberger GA · 1981
Acute and delayed effects of DSIP (delta sleep-inducing peptide) on human sleep behavior
International journal of clinical pharmacology, therapy, and toxicology · View source ↗Bes F, Hofman W, Schuur J, Van Boxtel C · 1992
Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind study
Neuropsychobiology · View source ↗Dick P, Costa C, Fayolle K, Grandjean ME, Khoshbeen A, Tissot R · 1984
DSIP in the treatment of withdrawal syndromes from alcohol and opiates
European neurology · View source ↗Larbig W, Gerber WD, Kluck M, Schoenenberger GA · 1984
Therapeutic effects of delta-sleep-inducing peptide (DSIP) in patients with chronic, pronounced pain episodes. A clinical pilot study
European neurology · View source ↗Schneider-Helmert D, Schoenenberger GA · 1983
Effects of DSIP in man. Multifunctional psychophysiological properties besides induction of natural sleep
Neuropsychobiology · View source ↗Yehuda S, Carasso RL · 1988
DSIP--a tool for investigating the sleep onset mechanism: a review
The International journal of neuroscience · View source ↗Tukhovskaya EA, Ismailova AM, Shaykhutdinova ER, Slashcheva GA, Prudchenko IA, Mikhaleva II, Khokhlova ON, Murashev AN, Ivanov VT · 2021
Delta Sleep-Inducing Peptide Recovers Motor Function in SD Rats after Focal Stroke
Molecules (Basel, Switzerland) · View source ↗· 2019
The influence of synthetic DSIP (delta-sleep-inducing-peptide) on disturbed human sleep
· 10.1007/bf01971753 View source ↗· 2019
Effects of delta-sleep-inducing peptide on 24-hour sleep-wake behaviour in severe chronic insomnia
· View source ↗· 2019
Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP)
· View source ↗· 2019
Delta sleep inducing peptide (DSIP): effect on respiration activity in rat brain mitochondria and stress protective potency under experimental hypo
· View source ↗· 2019
Effects of delta-sleep inducing peptide (DSIP) and some analogues on the activity of monoamine oxidase type A in rat brain under hypoxia stress
· View source ↗· 2019
Decreased concentrations of delta-sleep inducing peptide in plasma and cerebrospinal fluid from depressed patients: Nordisk Psykiatrisk Tidsskrift: Vol 39, No sup11
· 10.3109/08039488509101959 View source ↗· 2019
Delta sleep-inducing peptide (DSIP): An overview of central actions and possible relationship to psychiatric illnesses: Nordisk Psykiatrisk Tidsskrift: Vol 42, No 2
· 10.3109/08039488809103215 View source ↗· 2019
High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder
· View source ↗· 2019
Opioid detoxification with delta sleep-inducing peptide: results of an open clinical trial
· View source ↗· 2019
Effect of delta-sleep inducing peptide-containing preparation Deltaran on biomarkers of aging, life span and spontaneous tumor incidence in female
· View source ↗A. B. Sinyukhin, G. P. Timoshinov, V. A. Kornilov, and P. D. Shabanov · 2009
P.7.a.006 Delta sleep-inducing peptide analogue corrects the CNS functional state of children treated with antiblastomic therapy
Eur. Neuropsychopharmacol ·E. V. Koplik et al. · 2008
Delta sleep-inducing peptide and Deltaran: potential approaches to antistress protection
Neurosci. Behav. Physiol ·· 2019



